Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method

Abstract

Dynamic dialysis is one of the most common methods for the determination of release kinetics from nanoparticle drug delivery systems. Drug appearance in the "sink" receiver compartment is a consequence of release from the nanoparticles into the dialysis chamber followed by diffusion across the dialysis membrane. This dual barrier nature inherent in the method complicates data interpretation and may lead to incorrect conclusions regarding nanoparticle release half-lives. Although the need to consider the barrier properties of the dialysis membrane has long been recognized, there is insufficient quantitative appreciation for the role of the driving force for drug transport across that membrane. Reversible nanocarrier binding of the released drug reduces the driving force for drug transport across the dialysis membrane leading to a slower overall apparent release rate. This may lead to the conclusion that a given nanoparticle system will provide a sustained release in vivo when it will not. This study demonstrates these phenomena using model lipophilic drug-loaded liposomes varying in lipid composition to provide variations in bilayer permeability and membrane binding affinities. Model simulations of liposomal transport as measured by dynamic dialysis were conducted to illustrate the interplay between the liposome concentration, membrane/water partition coefficient, and the apparent release rate. Reliable determination of intrinsic liposomal bilayer permeability coefficients for lipophilic drugs by dynamic dialysis requires validation of drug release kinetics at varying nanoparticle concentration and the determination of membrane binding coefficients along with appropriate mechanism-based mathematical modeling to ensure the reliability and proper interpretation of the data.

Nanoemulsions in Translational Research—Opportunities and Challenges in Targeted Cancer Therapy

“…The drug released from a nanoparticle system has to diffuse through the dialysis chamber to reach the dialysis membrane to escape to the receiver compartment, presenting a double-barrier condition. Modi et al recently studied the drug release kinetics of a lipophilic drug from a liposomal formulation and demonstrated that several parameters should be considered to accurately and reliably predict the release kinetics of a drug (96).…”

The nasal delivery of nanoencapsulated statins – an approach for brain delivery

“…68 As already pointed out, the major drawback affecting the nasal administration is the removal of the formulation through the mucociliary clearance, a mechanism that can reduce the bioavailability of poorly water-soluble drugs. 52 Hence, fast absorption is required in order to achieve the needed therapeutic concentrations.…”

In vitro dissolution/release methods for mucosal delivery systems

“…The advantages of dialysis over other methods are in the ease of sampling and replacement of receptor media due to the physical separation of the formulation (by semipermeable dialysis membrane) from the receptor media. However, it is important to emphasize that non-critical interpretation of the obtained results can lead to flawed conclusions about the kinetics of drug release from the colloidal carriers [40,41] and other formulation types [42][43][44][45][46]. The presence of the drug in the receptor medium is the result of drug release from the carrier to the continuous phase in the donor compartment and diffusion of the drug through the membrane from the donor to the receptor compartment.…”